Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Mast cells might contribute to hair loss by causing skin thickening.

Human hair follicles can regenerate and recover after severe injury by going through a brief abnormal resting phase before growing again.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Lupus can cause hair loss and nail changes, with treatments available for both.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Glycerin in hand cream can cause allergic skin reactions.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Bee venom helps hair grow and may work better than some common treatments.